Blog

»  Posts By   September 2018 

Opioid Prescribing – Addressing Patients’ Needs While Avoiding Pitfalls

https://www.youtube.com/embed/IytgD0VHPUk In this recorded webinar, John E. Morrone, Esq., addresses opioid prescribing and avoiding pitfalls, including: • HHS’s 5-Point Strategy to Combat the Opioid Crisis • CDC Guidelines • State law limitation on prescribing • DEA enforcement and compliance • Compliance planning to avoid regulatory scrutiny • Naloxone prescribing and patient education This webinar will help prescribers: • Gain greater understanding of most up-to-date regulatory measures and enforcement actions •...

How Healthcare Providers’ Businesses Can Recover from the Impact of a Hurricane

Hurricanes, like the recent Hurricane Florence that hit North Carolina and South Carolina, can cause massive economic harm and property damage to physician practices, hospitals, pharmacies, and healthcare providers of all kinds. Business loss may include loss of patients, inventory, files, equipment, and the inability to continue operating the business. Other potential losses include the loss of payor contracts, adverse impact on wholesaler and distributor arrangements, licensing issues and prescription...

The California Insurance Commissioner’s Suit Against AbbVie Highlights Lurking Risks Under State Insurance Fraud Prevention Acts

Earlier this week, the California Insurance Commissioner filed a wide-ranging lawsuit against AbbVie, alleging classic illegal kickbacks to physicians as well as an intricate network of "nurse ambassadors" designed to improperly boost prescriptions for Humira, and seeking over $1.2 billion in damages.  Apart from representing a growing scrutiny on pharmaceutical manufacturers and other ancillary providers supplying nursing services allegedly in an effort to supplant the role of the prescribing physician,...

“Nurse Ambassadors” and California’s Suit Against AbbVie: The Growing Scrutiny of “White Coat Marketing”

Earlier this week, the California Insurance Commissioner filed a wide-ranging lawsuit against AbbVie, the maker of Humira, seeking over $1.2 billion in damages.  In addition to allegations of run-of-the-mill kickbacks to physicians, the lawsuit alleged an intricate network of "nurse ambassadors" designed to improperly boost prescriptions for Humira. This lawsuit, which was interestingly brought under California"s Insurance Frauds Prevention Act as part of a growing trend of State Insurance Commissioners...